These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 9225172)
1. Mode of action of orlistat. Guerciolini R Int J Obes Relat Metab Disord; 1997 Jun; 21 Suppl 3():S12-23. PubMed ID: 9225172 [TBL] [Abstract][Full Text] [Related]
2. Orlistat reduces gallbladder emptying by inhibition of CCK release in response to a test meal. Ellrichmann M; Ritter PR; Otte JM; Schrader H; Banasch M; Brunke G; Herzig KH; Seebeck J; Schmidt WE; Schmitz F Regul Pept; 2007 Mar; 139(1-3):136-40. PubMed ID: 17175037 [TBL] [Abstract][Full Text] [Related]
3. Orlistat maintains biliary lipid composition and hepatobiliary function in obese subjects undergoing moderate weight loss. Trouillot TE; Pace DG; McKinley C; Cockey L; Zhi J; Häeussler J; Guerciolini R; Showalter R; Everson GT Am J Gastroenterol; 2001 Jun; 96(6):1888-94. PubMed ID: 11421247 [TBL] [Abstract][Full Text] [Related]
4. The interaction of the lipase inhibitor orlistat with ethanol in healthy volunteers. Melia AT; Zhi J; Zelasko R; Hartmann D; Güzelhan C; Guerciolini R; Odink J Eur J Clin Pharmacol; 1998; 54(9-10):773-7. PubMed ID: 9923583 [TBL] [Abstract][Full Text] [Related]
5. Lipase inhibitor orlistat decreases incorporation of eicosapentaenoic and docosahexaenoic acids in rat tissues. Cruz-Hernandez C; Oliveira M; Pescia G; Moulin J; Masserey-Elmelegy I; Dionisi F; Destaillats F Nutr Res; 2010 Feb; 30(2):134-40. PubMed ID: 20226999 [TBL] [Abstract][Full Text] [Related]
6. Review of limited systemic absorption of orlistat, a lipase inhibitor, in healthy human volunteers. Zhi J; Melia AT; Eggers H; Joly R; Patel IH J Clin Pharmacol; 1995 Nov; 35(11):1103-8. PubMed ID: 8626884 [TBL] [Abstract][Full Text] [Related]
7. Influence of dietary composition on the inhibition of fat absorption by orlistat. Güzelhan C; Odink J; Niestijl Jansen-Zuidema JJ; Hartmann D J Int Med Res; 1994; 22(5):255-65. PubMed ID: 7867870 [TBL] [Abstract][Full Text] [Related]
8. Effect on dietary fat absorption of orlistat, administered at different times relative to meal intake. Hartmann D; Hussain Y; Güzelhan C; Odink J Br J Clin Pharmacol; 1993 Sep; 36(3):266-70. PubMed ID: 9114915 [TBL] [Abstract][Full Text] [Related]
9. Influence of orlistat on the regulation of gallbladder contraction in man: a randomized double-blind placebo-controlled crossover study. Froehlich F; Hartmann D; Guezelhan C; Gonvers JJ; Jansen JB; Fried M Dig Dis Sci; 1996 Dec; 41(12):2404-8. PubMed ID: 9011450 [TBL] [Abstract][Full Text] [Related]
10. Slowing down fat digestion and absorption by an oxadiazolone inhibitor targeting selectively gastric lipolysis. Point V; Bénarouche A; Zarrillo J; Guy A; Magnez R; Fonseca L; Raux B; Leclaire J; Buono G; Fotiadu F; Durand T; Carrière F; Vaysse C; Couëdelo L; Cavalier JF Eur J Med Chem; 2016 Nov; 123():834-848. PubMed ID: 27543878 [TBL] [Abstract][Full Text] [Related]
11. Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteers. Zhi J; Melia AT; Guerciolini R; Chung J; Kinberg J; Hauptman JB; Patel IH Clin Pharmacol Ther; 1994 Jul; 56(1):82-5. PubMed ID: 8033498 [TBL] [Abstract][Full Text] [Related]
13. Role of free fatty acids in regulating gastric emptying and gallbladder contraction. Degen L; Matzinger D; Drewe J; Nisslé S; Maecke H; Lengsfeld H; Hadvary P; Beglinger C Digestion; 2006; 74(3-4):131-9. PubMed ID: 17220631 [TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamic equivalence of two orlistat capsule formulations in healthy volunteers under fed conditions. Di Marco M; Marier JF; Ducharme MP; Morin I; Engel C; Gulbranson S; Thudi NR; Murpani D; Rampal A; Monif T; Koundinya TS; Deo K; Monif T Int J Clin Pharmacol Ther; 2008 Jun; 46(6):319-26. PubMed ID: 18541129 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the inhibition of dietary fat absorption by full versus divided doses of orlistat. Hussain Y; Güzelhan C; Odink J; van der Beek EJ; Hartmann D J Clin Pharmacol; 1994 Nov; 34(11):1121-5. PubMed ID: 7876405 [TBL] [Abstract][Full Text] [Related]
16. Reduction of dietary fat absorption by the novel gastrointestinal lipase inhibitor cetilistat in healthy volunteers. Bryson A; de la Motte S; Dunk C Br J Clin Pharmacol; 2009 Mar; 67(3):309-15. PubMed ID: 19220279 [TBL] [Abstract][Full Text] [Related]
18. The influence of reduced dietary fat absorption induced by orlistat on the pharmacokinetics of digoxin in healthy volunteers. Melia AT; Zhi J; Koss-Twardy SG; Min BH; Smith BL; Freundlich NL; Arora S; Passe SM J Clin Pharmacol; 1995 Aug; 35(8):840-3. PubMed ID: 8522642 [TBL] [Abstract][Full Text] [Related]